Work

Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule

Year: 1999

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s002800050971

Authors: James P. Stevenson, Deborah DeMaria, Denise Reilly, Joseph D. Purvis, Martin A. Graham, Graham Lockwood, Marion Drozd, Peter J. O'Dwyer

Institutions: Penn Presbyterian Medical Center, University of Pennsylvania, Fox Chase Cancer Center, Sanofi (United States)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: G7574495146

OpenAlex ID: W2074341351

FWCI: 0.689

Cites: 14

Cited by: 29

Related to: 10